Plan A male contraceptive
The Parsemus Foundation and its social venture subsidiary Revolution Contraceptives, LLC have partnered with NEXT Life Sciences to continue development of the Vasalgel male contraceptive. NEXT Life Sciences announced launch of Plan A birth control for men, using the Vasalgel technology.
Vasalgel male contraceptive has a new home
After a decade of research on Vasalgel, the Parsemus Foundation determined that the reversible, long-lasting contraceptive for men was ready to advance to the next level. The search began for an organization with the resources needed to lead the project to the marketplace, including clinical trials and regulatory review. The Parsemus Foundation selected NEXT Life Sciences, Inc. as that partner. NEXT Life Sciences’ mission is to develop and distribute medical technology that empowers people to choose when and whether to have a child.
NEXT Life Sciences announced its launch of the product called Plan A, using the Vasalgel technology for male contraception. The NEXT team expects Plan A to be available to the public in 2026.
For more information, see the NEXT Life Sciences and Plan A websites.
How to stay engaged with Vasalgel
Stay Connected
- Sign up for updates on Vasalgel from NEXT Life Sciences.
Visit the NEXT Life Sciences Plan A website
- Visit the NEXT LifeSciences Plan A website to get more information on Vasalgel.
- Last updated on March 27, 2023
Reproductive Health News
Plan A male contraceptive launched using Vasalgel technology
NEXT Life Sciences announced the launch of the Plan A™ male contraceptive. NEXT took over development of Vasalgel, which is the technology used in Plan
Funding for undergrad research on male contraception
The Male Contraceptive Initiative Youth Advisory Board is offering a grant to undergraduate students for research on male contraception. Undergraduate students anywhere in the world
NEXT steps for Vasalgel
The Parsemus Foundation and Revolution Contraceptives LLC are pleased to announce that NEXT Life Sciences, Inc. has been selected to continue development of the Vasalgel
Plan A male contraceptive launched using Vasalgel technology
NEXT Life Sciences announced the launch of the Plan A™ male contraceptive. NEXT took over development of Vasalgel, which is the technology used in Plan
Funding for undergrad research on male contraception
The Male Contraceptive Initiative Youth Advisory Board is offering a grant to undergraduate students for research on male contraception. Undergraduate students anywhere in the world
NEXT steps for Vasalgel
The Parsemus Foundation and Revolution Contraceptives LLC are pleased to announce that NEXT Life Sciences, Inc. has been selected to continue development of the Vasalgel
Supporting the future of male contraceptive research
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
